Bortero 2 mg Injection
  1. Home
  2. Pharma Products
  3. Hetero Healthcare Ltd
  4. Bortero 2 mg Injection

Bortero 2 mg Injection

Bortero 2 mg Injection contains bortezomib 2 mg and is an injectable anticancer medicine used in the treatment of certain blood cancers. It is used for multiple myeloma and mantle cell lymphoma in adults as part of prescribed cancer treatment regimens. The medicine is administered by a qualified healthcare professional through intravenous or subcutaneous injection.

BUY NOW

Category

Bortezomib is a proteasome inhibitor that blocks protein breakdown inside cancer cells, causing accumulation of unwanted proteins and promoting cancer-cell death. It may be used alone or in combination with other anticancer medicines depending on the patient’s disease and treatment protocol. Regular monitoring of blood counts and other clinical parameters may be required because treatment can cause effects such as low blood-cell counts, peripheral neuropathy, gastrointestinal symptoms, and infections. The dose and administration schedule are determined by the treating specialist based on the indication and patient’s clinical condition.

Technical Specification

Specification Details
Active Ingredient Bortezomib
Strength 2 mg
Dosage Form Injection
Route of Administration Intravenous or Subcutaneous
Pack Size 1 vial
Manufacturer Hetero Healthcare Ltd.

Product Also Known As

Bortero 2mg Injection, Bortero 2 mg Injection, Bortero Injection 2mg, Bortezomib 2mg Injection, Bortezomib 2 mg Injection, Bortezomib Injection 2mg, Bortezomib 2mg Vial